At the news
? BEARISHIMPACT 6/10 PRESS-RELEASE filed Nov 12, 2026 at 07:00 ET
MediWound reported Q3 2026 revenue of $3.6M, down 33% YoY from $5.4M, and a net loss of $0.46 per share, wider than the consensus EPS estimate of -$0.73. The company's 2026 revenue outlook is uncertain due to ongoing U.S. government funding discussions for a planned manufacturing facility. A $17.25M public offering closed after quarter-end strengthens the balance sheet but adds dilution.
- Q3 2026 revenue $3.6M, down 33% YoY from $5.4M
- Net loss $0.46 per share vs consensus -$0.73 (beat on EPS)
- Operating loss widened to $8.5M from $6.5M YoY
- Cash burn $28.3M in first nine months; cash fell to $28.4M from $53.6M at year-end 2025
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access